Line 1: |
Line 1: |
| + | Welcome! |
| | | |
− | {| class="wikitable sortable"
| + | |
− | |+Gene-Specific Pages
| + | We are creating content for all diseases with genetic findings in the current WHO Classification of Tumours books. Please join the effort! |
− | !'''Gene'''
| + | |
− | !'''Author'''
| + | |
− | !'''Date Assigned to Author'''
| + | To volunteer: |
− | !'''Target Completion Date'''
| + | |
− | !'''Author Content (Pending or Complete)'''
| + | #Select a link in the table to your book(s) of interest to view specific authorship opportunities. Additional books are in the process of being added. |
− | !'''Date Completed by Author'''
| + | #'''[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]''' with your disease page of interest. You will be connected with an Associate Editor to help guide you through the process. |
− | !'''Associate Editor''' | + | #Complete the brief '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]''' to receive your log-in credentials. Information on [[Description of CCGA Roles|<u>Authorship and Other Roles</u>]] with the CCGA is available. |
− | !'''Date of Last Editor Review''' | + | |
− | !'''Notes''' | + | |
| + | {| class="wikitable" |
| + | |+BOOKS WITH CONTENT IN PROGRESS |
| + | !Book Name |
| + | !Book Edition |
| + | !Book Acronym |
| |- | | |- |
− | |BCR | + | |[[HAEM5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues]] |
− | |Brian Davis
| + | |5th |
− | |
| + | |HAEM5 |
− | |
| |
− | |Complete
| |
− | |8/10/18
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | |ABL1 | + | |[[CNS5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Central Nervous System]] |
− | |Brian Davis
| + | |5th |
− | |
| + | |CNS5 |
− | |
| |
− | |Complete
| |
− | |4/16/19
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | |RUNX1 | + | |[[GTS5:Volunteer Assignments and Opportunities|WHO Classification of Genetic Tumour Syndromes]] |
− | |Brian Davis
| + | |5th |
− | |
| + | |GTS5 |
− | |
| |
− | |Complete
| |
− | |6/9/19
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | |RUNX1T1 | + | |[[BRST5:Volunteer Assignments and Opportunities|WHO Classification of Tumours of the Breast]] |
− | |Brian Davis
| + | |5th |
− | |
| + | |BRST5 |
− | |
| |
− | |Complete
| |
− | |5/23/19
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | |MYH11 | + | |[[STBT5:Volunteer Assignments and Opportunities|WHO Classification of Soft Tissue and Bone Tumours]] |
− | |Brian Davis
| + | |5th |
− | |
| + | |STBT5 |
− | |
| |
− | |Complete
| |
− | |8/6/18
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | |FLT3 | + | |[[DIG5:Volunteer Assignments and Opportunities|WHO Classification of Digestive System Tumours]] |
− | |Kay Weng Choy
| + | |5th |
− | |
| + | |DIG5 |
− | |
| + | |} |
− | |Complete
| + | |
− | |
| + | |
− | |
| + | {| class="wikitable" |
− | |
| + | |+BOOKS COMING SOON |
− | |
| + | !Book Name |
− | |-
| + | !Book Edition |
− | |NPM1
| + | !Book Acronym |
− | |Kay Weng Choy
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |TP53
| |
− | |Kay Weng Choy
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |DNMT3A
| |
− | |Kay Weng Choy
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |CEBPA
| |
− | |Gordana
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |IDH1
| |
− | |Paul De Fazio
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |IDH2
| |
− | |Paul De Fazio
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |PML
| |
− | |Brian Davis
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |12/5/18
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |RARA
| |
− | |Brian Davis
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |8/3/18
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |ETV6
| |
− | |Brian Davis
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |6/9/19
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |KIT
| |
− | |Brian Davis
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |10/1/18
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |CBFB
| |
− | |Brian Davis
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |8/2/18
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |GATA2
| |
− | |Kay Weng Choy
| |
− | |
| |
− | |
| |
− | |Complete
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |PTEN
| |
− | |Beth Pitel
| |
− | |
| |
− | |
| |
− | |Pending
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |MLTT3
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |MECOM
| |
− | |Brian Davis
| |
− | |
| |
− | |
| |
− | |Pending
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |FGFR1(FLT2)
| |
− | |Brian Davis
| |
− | |
| |
− | |
| |
− | |Pending
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |KMT2A
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |DEK
| |
− | |Wahab A. Khan
| |
− | |
| |
− | |
| |
− | |Pending
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |NUP214
| |
− | |Wahab A. Khan
| |
− | |
| |
− | |
| |
− | |Pending
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |RBM15
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |MKL1
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |DDX41
| |
− | |Ying Zou
| |
− | |8/7/20
| |
− | |
| |
− | |Pending
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |ANKRD26
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |CUX1
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |TET2
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |EZH2
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |FOXP1
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |MYC
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |JAK2
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |WT1
| |
− | |DONE
| |
− | |
| |
− | |
| |
− | |DONE
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |CBL
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |NF1
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |SUZ12
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |ERG
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |EST2
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |RPS14
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |RB1
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |MPL
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |CHGA
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |CDH1
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |SRSF2
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |DNMT1
| |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
− | | | |
− | |
| |
− | |-
| |
− | |PRDX2 | |
− | | | |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
− | |-
| |
− | |ASXL1
| |
− | |DONE
| |
− | |
| |
− | |
| |
− | |DONE
| |
− | |
| |
− | |
| |
− | |
| |
− | |
| |
| |- | | |- |
− | |MN1 | + | |[[EYE5:Volunteer Assignments and Opportunities|WHO Classification of Eye and Orbit Tumours]] |
− | |
| + | |5th |
− | |
| + | |EYE5 |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | |SF3A1 | + | |[[SKIN5:Volunteer Assignments and Opportunities|WHO Classification of Skin Tumours]] |
− | |
| + | |5th |
− | |
| + | |SKIN5 |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | |EP300 | + | |[[HAN5:Volunteer Assignments and Opportunities|WHO Classification of Head and Neck Tumours]] |
− | |
| + | |5th |
− | |
| + | |HAN5 |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | |JARID2 | + | |[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]] |
− | |
| + | |5th |
− | |
| + | |ENDO5 |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | | | + | |[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]] |
− | |
| + | |5th |
− | |
| + | |MALE5 |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | | | + | |[[PEDS5:Volunteer Assignments and Opportunities|WHO Classification of Paediatric Tumours]] |
− | |
| + | |5th |
− | |
| + | |PEDS5 |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | | | + | |[[THOR5:Volunteer Assignments and Opportunities|WHO Classification of Thoracic Tumours]] |
− | |
| + | |5th |
− | |
| + | |THOR5 |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
| |- | | |- |
− | | | + | |[[FEMA5:Volunteer Assignments and Opportunities|WHO Classification of Female Genital Tumours]] |
− | |
| + | |5th |
− | |
| + | |FEMA5 |
− | |
| |
− | |
| |
− | |
| |
− | | | |
− | | | |
− | | | |
| |} | | |} |